
Prakhar Panchbhaiya
Assistant Manager: Business Insights and Content
Supporting procurement teams with category intelligence, market research, price trends, supply-demand analysis, and strategic sourcing insights across key industries.

Furandicarboxylic acid has moved from formulation trials to commercial commitment. On 12 November, Avantium and specialty chemical distributor Will & Co signed a capacity reservation agreement covering future licensed production of the sugar-derived monomer, aimed at the coatings, adhesives, sealants and elastomers sectors rather than at packaging alone. The two had worked together on application validation since February, so the reservation marks the point at which that work converted into a supply claim.
The structure of the agreement matters more than its size. Rather than drawing volume from Avantium’s first commercial facility at Delfzijl in the Netherlands, the reservation secures interest in output from future industrial plants run by prospective licensees of the company’s YXY process. Buyers are reserving a position in a licensing pipeline that has no physical form yet, which suits formulators who need a credible decarbonisation route on a multi-year view and suits the licensor’s capital-light expansion plan.
Request the Latest Polyurethane Prices Data - Access Price Insights Now
Demand for the monomer has been building for reasons beyond packaging. Formulators in the coatings and adhesives chain use it to make alkyd resins for architectural and protective paints, polyester polyols for polyurethane adhesives and flexible foams, and specialty surfactants and elastomers for automotive, construction, flooring and tubing applications. Each of those routes depends on petroleum feedstocks today, which makes a renewable substitute commercially interesting whatever happens to bioplastic adoption rates.
The reservation came a day after an equity raise completed on 11 November, and that raise is the part buyers should weigh most carefully. Avantium issued 33.6 million new shares at 1.65 euros each to bring in 55.45 million euros, with existing shareholders taking 85.7 percent through a rights issue and the balance placed. Invest-NL subscribed just over 6 million euros and Pieter Kooi Holding 5 million, while Invest-NL, ABN Amro, BNP Paribas and Stifel underwrote the remaining 42 million. Proceeds fund the Delfzijl start-up, the first commercial deliveries and the licensing programme.
The disclosures that came with it show how tight the position is. Cash stood at 23.9 million euros at the end of June against 57.5 million at the end of 2025, the first-half loss before interest, tax, depreciation and amortisation reached 18.8 million euros, revenue fell to 4.7 million from 6.7 million, and titanium weld remediation added 7 million euros in costs. The company projects a 33 million euro working capital shortfall over twelve months. A 20 million euro development loan is structured in four tranches tied to milestones, with the first not expected before March 2027 and subject to regional and national approval. The issue price sat well below the theoretical ex-rights level, and the shares traded at 1.95 euros on 12 November.
Formulators weighing a switch should treat the reservation as an option rather than a guarantee. The plant has produced its first material and first commercial deliveries are targeted before the year ends, but the move from batch to continuous operation is expected to take twelve to twenty-four months, and 23 offtake agreements and 17 reservations already cover more than 150 kilotonnes of annual capacity that does not yet run continuously. Anyone reformulating around this acid should keep a petroleum-based fallback qualified through 2027 and tie commitments to demonstrated continuous output rather than to nameplate.

Assistant Manager: Business Insights and Content
Supporting procurement teams with category intelligence, market research, price trends, supply-demand analysis, and strategic sourcing insights across key industries.





We are Just a Text away